Medicine and Dentistry
Patient
82%
Amyotrophic Lateral Sclerosis
68%
Symptom
63%
Respiratory Muscle
47%
Dyspnea
42%
COVID-19
31%
Survival
31%
Population Research
31%
Disease
31%
Biological Marker
31%
Noninvasive Ventilation
31%
Gastrostomy
31%
Muscle Strength
31%
Functional Disease
31%
Pneumonia
31%
Thorax Radiography
31%
Assessment
23%
Muscle Weakness
14%
Death
13%
Walking Speed
10%
Mental Health
10%
Caregiver
10%
Psychosocial Factor
10%
Sequela
10%
Screening
10%
Age
9%
Predictor
7%
Mouth
7%
Prognosis
7%
Measurement
7%
Deterioration
7%
Therapeutic Procedure
5%
Depression
5%
Posttraumatic Stress Disorder
5%
Patient Health Questionnaire 9
5%
Male
5%
Computer Assisted Tomography
5%
Muscle Function
5%
Ensure
5%
Community-Acquired Pneumonia
5%
Follow up
5%
Body Mass Index
5%
Symptomatic Treatment
5%
Respiratory Failure
5%
Oxygen Consumption
5%
Diagnosis
5%
Mass Screening
5%
Health Outcomes
5%
Cohort Study
5%
Recognition
5%
Nursing and Health Professions
Amyotrophic Lateral Sclerosis
100%
Diseases
67%
Noninvasive Ventilation
63%
Gastrostomy
63%
Control
39%
Symptom
38%
Patient
36%
Dyspnea
31%
Psychological Aspect
31%
Health Care Personnel
31%
Caregiver
18%
Muscle Weakness
10%
Depression
7%
Variance
7%
Ensure
5%
Continuous Positive Airway Pressure
5%
Death
5%
Diagnosis
5%
Palliative Therapy
5%
Respiratory Failure
5%
Tracheostomy
5%
Psychology
Mood
31%
Decision Making
14%
Demographics
10%
Illness Perceptions
10%
Questionnaires
8%
Treatment
8%
Multiple Regression
7%
Palliative Care
5%
Interviews
5%
Caregiver
5%
Complexities
5%
